Jerome H. Fleisch

Jerome H. Fleisch

Corporate Officer/Principal presso
Society of Critical Care Medicine
Consumer Services
Health Technology
Government

Profilo

Prior to joining Pearl Street, Dr. Fleisch retired as a Distinguished Research Fellow in 2002 after 28 years at Lilly.
Internationally recognized as an expert in drug development, having led several multidisciplinary research teams in the discovery of and the quest to advance approximately 12 new chemical entities into clinical trials.
Well published in peer reviewed journals, Dr. Fleisch holds chemical and biological patents and has served on scientific journal editorial review boards.
He is a member of the American Society for Pharmacology and Experimental Therapeutics, the American Thoracic Society, the Inflammation Research Association and the Society of Critical Care Medicine.
He is currently an Adjunct Professor in the Department of Surgery, Indiana University School of Medicine.
Dr. Fleisch has a BS in Pharmacy from Columbia University, New York, a Ph.D.
in Pharmacology from Georgetown University, Washington, DC, and completed a Postdoctoral Fellowship at Harvard Medical School.

Posizioni attive di Jerome H. Fleisch

SocietàPosizioneInizio
Corporate Officer/Principal -
Corporate Officer/Principal -

Precedenti posizioni note di Jerome H. Fleisch

SocietàPosizioneFine
Investitore di Private Equity 01/04/2010
ELI LILLY AND COMPANY Corporate Officer/Principal 31/12/2001
Corporate Officer/Principal -
Vedi nel dettaglio l'esperienza di Jerome H. Fleisch

Formazione di Jerome H. Fleisch

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

93

Relazioni di 1° grado

7

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private7

Health Technology

Consumer Services

Consumer Services

Consumer Services

Government

Finance

Commercial Services

  1. Mercati
  2. Insiders
  3. Jerome H. Fleisch